“What a Headache!” (or Maybe Not): 2021 Migraine Treatment Updates

“What a Headache!” (or Maybe Not): 2021 Migraine Treatment Updates

12% of adults experience disabling migraines. Fortunately, there are multiple new medications. Take this course to learn about the new medications and how providers select which medication to prescribe.

Upon successful completion of this knowledge-based CPE course, pharmacy technicians should be able to:
1. List the brand/generic names and indication(s) of new drugs approved for treatment of migraines
2. Define the following terms: aura, medication overuse headache, medication-use headache
3. Explain the factors impacting the selection of therapies for migraines

Nicholas Cox, PharmD, BCACP
Assistant Professor
University of Utah

Nicholas Cox does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: September 1, 2021
Planned Expiration Date: September 1, 2024

Copyright 2021, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

Universal Activity Number (UAN): 0107-0000-21-271-H01-T
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information


0h 45m

Topic Designator

Disease State/Drug Therapy



ACPE Topic

01 Drug Therapy





Release Date






ACPE Number


This course is in our subscription.